3/11
02:05 pm
lgnd
Ligand Pharmaceuticals offers high-margin exposure to biopharma growth, BofA says [Yahoo! Finance]
Low
Report
Ligand Pharmaceuticals offers high-margin exposure to biopharma growth, BofA says [Yahoo! Finance]
3/11
08:03 am
lgnd
Ligand Pharmaceuticals (LGND) is now covered by Bank of America Corporation. They set a "buy" rating and a $244.00 price target on the stock.
Medium
Report
Ligand Pharmaceuticals (LGND) is now covered by Bank of America Corporation. They set a "buy" rating and a $244.00 price target on the stock.
3/7
07:53 pm
lgnd
How The Ligand Pharmaceuticals (LGND) Story Is Shifting Around QTORIN And Royalty Growth [Yahoo! Finance]
Medium
Report
How The Ligand Pharmaceuticals (LGND) Story Is Shifting Around QTORIN And Royalty Growth [Yahoo! Finance]
3/4
07:25 am
lgnd
Ligand to Participate in March Investor Conferences [Yahoo! Finance]
Low
Report
Ligand to Participate in March Investor Conferences [Yahoo! Finance]
3/4
07:00 am
lgnd
Ligand to Participate in March Investor Conferences
Low
Report
Ligand to Participate in March Investor Conferences
3/2
12:12 am
lgnd
Ligand Pharmaceuticals (LGND) Is Up 7.8% After Swing to Profit and New ATM Offering Filed – Has The Bull Case Changed? [Yahoo! Finance]
Medium
Report
Ligand Pharmaceuticals (LGND) Is Up 7.8% After Swing to Profit and New ATM Offering Filed – Has The Bull Case Changed? [Yahoo! Finance]
2/27
10:58 am
lgnd
Ligand Pharmaceuticals (LGND) had its price target raised by Oppenheimer Holdings, Inc. from $275.00 to $277.00. They now have an "outperform" rating on the stock.
Low
Report
Ligand Pharmaceuticals (LGND) had its price target raised by Oppenheimer Holdings, Inc. from $275.00 to $277.00. They now have an "outperform" rating on the stock.
2/26
05:33 pm
lgnd
Ligand Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Ligand Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
04:50 pm
lgnd
Ligand Pharma (LGND) Earnings Call Transcript [Yahoo! Finance]
Low
Report
Ligand Pharma (LGND) Earnings Call Transcript [Yahoo! Finance]
2/26
07:59 am
lgnd
Ligand: Q4 Earnings Snapshot [Yahoo! Finance]
Low
Report
Ligand: Q4 Earnings Snapshot [Yahoo! Finance]
2/26
07:32 am
lgnd
Ligand Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Ligand Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
2/26
07:00 am
lgnd
Ligand Reports Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Ligand Reports Fourth Quarter and Full Year 2025 Financial Results
2/24
01:35 pm
lgnd
Ligand Pharmaceuticals (NASDAQ:LGND) had its price target raised by analysts at HC Wainwright from $231.00 to $239.00. They now have a "buy" rating on the stock.
Low
Report
Ligand Pharmaceuticals (NASDAQ:LGND) had its price target raised by analysts at HC Wainwright from $231.00 to $239.00. They now have a "buy" rating on the stock.
2/15
02:13 am
lgnd
Assessing Ligand Pharmaceuticals (LGND) Valuation After Recent Mixed Share Price Performance [Yahoo! Finance]
Low
Report
Assessing Ligand Pharmaceuticals (LGND) Valuation After Recent Mixed Share Price Performance [Yahoo! Finance]
2/12
07:00 am
lgnd
Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Low
Report
Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
2/4
07:00 am
lgnd
Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Low
Report
Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference